Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihistamines.

Scott C Armstrong1, Kelly L Cozza

  • 1Center for Geriatric Psychiatry, Tuality Forest Grove Hospital, Forest Grove, OR 97116, USA. scott.armstrong@tuality.org

Psychosomatics
|September 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obtaining and Documenting Informed Consent: An Advanced UME Cross-Specialty, Role-Playing Skill Builder.

MedEdPORTAL : the journal of teaching and learning resources·2026
Same author

Building Faculty Performance Evaluation from the Ground-Up: Designing Tools and Gauging Acceptance.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2025
Same author

The Effectiveness of Online Experiential Learning in a Psychiatry Clerkship.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2023
Same author

Psychotropic Medication Informed Consent: A Cross-Specialty Role-Playing Skill Builder.

MedEdPORTAL : the journal of teaching and learning resources·2021
Same author

Experiential Learning Cycles as an Effective Means for Teaching Psychiatric Clinical Skills via Repeated Simulation in the Psychiatry Clerkship.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2020
Same author

Updates in Consultation-Liaison Psychiatry: 2019.

Psychosomatics·2020
Same journal

Clinical Approach to Personality Change Due to Another Medical Condition.

Psychosomatics·2021
Same journal

Clonazepam for Catatonia Incompletely Responsive to lorazepam.

Psychosomatics·2021
Same journal

Diabetic Retinopathy and Depression: A Risk Assessment.

Psychosomatics·2021
Same journal

WITHDRAWN: Psychosis: A Presentation of COVID-19?

Psychosomatics·2021
Same journal

Dermatitis Neglecta, the Cognitive Assessment, and Micronutrients.

Psychosomatics·2020
Same journal

Coronavirus and Its Implications for Psychiatry: A Rapid Review of the Early Literature.

Psychosomatics·2020
See all related articles

Sedating antihistamines can inhibit the CYP 2D6 enzyme, potentially causing drug interactions. Newer, nonsedating antihistamines show no serious drug interactions or cardiotoxicity at recommended doses.

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Medicinal Chemistry

Background:

  • Antihistamines are widely used for allergic conditions.
  • Understanding drug metabolism is crucial for drug safety.
  • Previous antihistamines (terfenadine, astemizole) were withdrawn due to cardiotoxicity linked to cytochrome P450 interactions.

Purpose of the Study:

  • To review antihistamines and their drug-drug interactions.
  • To highlight the importance of the cytochrome P450 system in antihistamine metabolism and safety.
  • To compare different generations of antihistamines regarding their interaction profiles.

Main Methods:

  • In vivo and in vitro studies were used to investigate antihistamine metabolism.
  • Literature review of sedating, second-generation, and third-generation antihistamines.

Related Experiment Videos

  • Analysis of drug interaction data and cardiotoxicity reports.

    • Main Results:

    • "Classic" sedating antihistamines are metabolized by CYP 2D6.
    • Many sedating antihistamines potently inhibit the polymorphic CYP 2D6 enzyme.
    • Third-generation nonsedating antihistamines have been scrutinized and show no serious drug interactions or cardiotoxicity at recommended doses.

    Conclusions:

    • The cytochrome P450 system, particularly CYP 2D6, plays a significant role in antihistamine drug interactions.
    • Understanding these interactions is vital for patient safety.
    • Third-generation antihistamines represent a safer option regarding drug-drug interactions and cardiotoxicity.